Barinthus Biotherapeutics plc.
BRNSDelisted Sep 9, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828185
Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Barinthus Biotherapeutics plc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q3 2023
- Shares held
- 9.72M
- +11.5K (+0.1%) vs. Q3 2023
- Total value
- $36.5M
- +$7.01M (+23.7%) vs. Q3 2023
- New holders
- 1
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $7.84M |
| Q1 2026 | 14 | $7.89M |
| Q4 2025 | 13 | $6.10M |
| Q3 2025 | 15 | $10.4M |
| Q2 2025 | 14 | $9.02M |
| Q1 2025 | 15 | $9.15M |
| Q4 2024 | 16 | $10.3M |
| Q3 2024 | 19 | $10.7M |
| Q2 2024 | 18 | $11.8M |
| Q1 2024 | 15 | $21.3M |
| Q4 2023 | 15 | $36.5M |
| Q3 2023 | 16 | $29.5M |
| Q2 2023 | 15 | $20.0M |
| Q1 2023 | 13 | $21.6M |
| Q4 2022 | 15 | $22.2M |
| Q3 2022 | 11 | $31.2M |
| Q2 2022 | 13 | $27.5M |
| Q1 2022 | 12 | $23.8M |
| Q4 2021 | 15 | $54.3M |
| Q3 2021 | 15 | $77.6M |
| Q2 2021 | 19 | $76.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Barinthus Biotherapeutics plc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| M&G Investment Management Ltd | 5,197,349 | $20.8M | 0.12% | 00.0% | Unchanged |
| Alphabet Inc. | 1,513,644 | $5.59M | 0.26% | 00.0% | Unchanged |
| SC China Holding Ltd | 1,420,473 | $4.30M | 0.50% | 00.0% | Unchanged |
| DC Funds, LP | 642,204 | $2.37M | 28.49% | 00.0% | Unchanged |
| BlueCrest Capital Management Ltd | 542,673 | $2.00M | 0.33% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 196,296 | $724.3K | 0.00% | 00.0% | Unchanged |
| Johns Hopkins University | 107,968 | $398.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 29,699 | $110.0K | 0.00% | +8,299+38.8% | Added |
| Ipswich Investment Management Co., Inc. | 23,075 | $85.1K | 0.02% | −4,000−14.8% | Reduced |
| Morgan Stanley | 16,467 | $60.8K | 0.00% | −4,748−22.4% | Reduced |
| Janney Montgomery Scott LLC | 15,008 | $55.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 11,568 | $41.2K | 0.00% | +11,568 | New |
| UBS Group AG | 1,547 | $5.71K | 0.00% | +1,458+1,638.2% | Added |
| New England Capital Financial Advisors LLC | 104 | $384 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 60 | $213 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −100−100.0% | Sold out |